BARCELONA, Spain & MARIN, Calif.--(BUSINESS WIRE)--Nov 19, 2026--
Anaconda Biomed, a medical technology company developing a next-generation portfolio of novel thrombectomy catheters based on its core funnel catheter technology platform, has announced the appointment of Omar Azanki to chief technology officer. Azanki joins Anaconda from Edwards Lifesciences, where he most recently served as senior director of advanced technology R&D.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261119509766/en/
“Omar brings a wealth of strategic, technical and operational excellence to Anaconda. As the senior director of the Advanced Technology R&D group at Edwards Lifesciences over the last 16 years, he has led a broad range of critical work from early human development to the transfer and integration of developed technologies,” said Trent Reutiman, CEO of Anaconda Biomed. “Omar’s skill set and expertise from within the U.S. adds an extra dimension to our current R&D capabilities, and he will ensure that we consider vendors and partners in the U.S. where prototyping and iteration pace is quick and competitive.”
Azanki brings more than 24 years of experience leading multi-disciplinary R&D teams through the full lifecycle of Class III medical devices, from early concept to global commercialization. He holds a Master of Science in engineering management from the New Jersey Institute of Technology and a Bachelor of Engineering in mechanical engineering from the American University of Beirut.
His appointment follows a $56 million financing round announced by Anaconda in September.
“Anaconda’s proprietary funnel catheter platform represents a compelling opportunity in neurovascular care, directly addressing the clinical challenges of clot capture and distal embolization during stroke intervention,” said Azanki. “Coming off the momentum of the company’s recent financing, I am thrilled to join the team to help bring this next-generation portfolio to physicians and patients worldwide.”
About Anaconda Biomed
Anaconda Biomed is an innovative medical technology company dedicated to reducing disability and death caused by stroke and other neurovascular diseases. Anaconda’s proprietary Funnel Catheter platform is a novel endovascular technology designed to improve clot capture, reduce embolic complications and maximize brain reperfusion. By combining aspiration power similar to large-bore catheters with the flow-arrest and flow-reversal benefits typically associated with balloon guide catheters, Anaconda seeks to capture microemboli before they cause new vessel occlusions, supporting more complete reperfusion, while maximizing clot retrieval with fewer device passes.
Anaconda is developing a portfolio of products built on this technology, spanning mechanical thrombectomy, aspiration-first stroke treatment and carotid interventions, with multiple sizes of the ANA Funnel along with the Conda stent retriever.
The ANA Funnel Catheter is an investigational device in the United States. Limited by United States law to investigational use. The ANA5 Funnel Catheter is CE mark approved.
For more information, please visit https://anaconda.bio and follow the company on LinkedIn.
Anaconda Biomed has announced the appointment of Omar Azanki to chief technology officer. Azanki joins Anaconda from Edwards Lifesciences, where he most recently served as senior director of advanced technology R&D.
NEW YORK (AP) — Walmart reported solid third-quarter sales gains as the retailer continues to attract a growing number of customers across the economic spectrum that are seeking to cut costs in the face of rising prices.
The company topped Wall Street’s profit and sales projections, and it raised its annual guidance for the third time this year, but the outlook released Thursday was more conservative than industry analysts had expected.
Shares fell about 1.5% in morning trading.
Comparable sales, which include digital channels and stores, rose 2.9%. That is better than last quarter's 2.6% increase, when Walmart reported its weakest comparable sales growth in six years. But it's still a slowdown from the 4.5% growth registered during the same period last year.
Still, slowing comparable sales, particularly in Walmart stores, also reflect a strategic shift toward e-commerce, Walmart+ memberships and advertising. Global e-commerce sales rose 17%, while U.S. e-commerce sales increased 23% during the latest quarter, the company said. And the company's advertising business was up 37%, the retailer said.
Walmart said that more than 80% of U.S. e-commerce orders are being fulfilled from stores, including its third-party marketplace orders. Stores enabled faster delivery speeds on a wide range of assortments, the retailer said.
Walmart's CEO John Furner told analysts during a call following the earnings release that e-commerce was the “primary driver again this quarter.”
“We continued to gain market share, units and transactions were strong, and looking ahead, we expect a strong holiday season,” he added.
Walmart is considered a barometer of consumer spending given its vast customer base. More than 150 million customers use its website or visit its stores every week, according to Walmart. Analysts look to the massive retailer for clues about what to expect from the industry as a whole during the critical holiday shopping season.
Consumers in the U.S. have remained resilient in the face of painful inflation, but they have also grown more selective about what they buy. Many rely on retailers like Walmart as a one-stop shop for low-priced household goods, groceries and pharmaceuticals.
The latest U.S. retail sales data revealed that shoppers increased spending more slowly in October as Americans pulled back on a variety of purchases, from cars and clothing to furniture and even their own hobbies.
Retail sales rose 0.2% in October, down from a 0.8% gain in September, according to Commerce Department data released this week.
Walmart has been hammering its low price message while refining its store-label fashion brands like Scoop and Free Assembly.
Walmart is also trying to increase subscriptions to its shipping programs. During the third quarter, Walmart launched a combined Walmart+ and Sam’s Club Plus annual membership bundle for $120 per year. The package saves shoppers nearly $100 compared to buying both plans separately, it said.
Walmart, based in Bentonville, Arkansas, has begun to capture a larger share of wealthier consumers. The biggest gains in market share for Walmart have been coming from households with annual incomes over $100,000, the retailer has said.
Walmart’s quarterly net income was $4.94 billion, or 62 cents per share, in the three-month period ended Oct. 31. Adjusted per-share results were 65 cents, higher than the 64 cents Wall Street had expected, according to FactSet. In the year-ago quarter, the company earned $6.14 billion, or 77 cents per share.
Sales rose 5.2% to $188.8 billion in the latest quarter. Analysts were predicting $187.38 billion, according to FactSet.
The company said that comparable sales were driven by groceries and general merchandise categories like furniture and toys. Walmart said that its grocery business enjoyed the highest market share gains in three years, driven by low prices and faster delivery speeds.
During the fiscal second quarter, Walmart used U.S. tariff refunds to temporarily lower prices on 11,000 items. At the end of the fiscal third period, Walmart had about 7,700 so-called rollbacks, the retailer said.
But the retailer's health and wellness category was once again hit by federal legislation that requires pharmacies to dispense some high-cost Medicare drugs at capped prices, the retailer said. Excluding that category, comparable sales were up 3.6%, Walmart said.
“Walmart continues to capture new customers as well as retaining the ones they secured over the past couple of years,” Neil Saunders, managing director of GlobalData Retail, wrote in a report. “A lot of the switching to Walmart is initially driven by price, which remains the major weapon in Walmart’s armory.”
For the full year, Walmart now projects earnings per share to be in the range of $2.84 to $2.89, up from the prior guidance of $2.80 to $2.87. Sales should be up anywhere from 4.9% to 5.2%, up from the prior forecast of 4% to 5%. That would mean a forecast for sales in the range of $748.12 billion to $750.25 billion, according to FactSet.
Analysts expected $2.89 per share and sales of $752.68 billion for the year, according to FactSet.
FILE - The Walmart logo is displayed on a store, Aug. 14, 2025, in Manchester, N.H. (AP Photo/Charles Krupa, File)